Dimethylformamide → 5-Allyl-3-methyl-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one
Reaction equation
[CH2:1]([N:4]1[C:12]2C(Cl)=NC=[N:8][C:7]=2[CH:6]=[CH:5]1)[CH:2]=[CH2:3].[H-].[Na+].CI.[CH3:18][N:19]([CH:21]=[O:22])[CH3:20]>O>[CH2:1]([N:4]1[C:12]2[C:21](=[O:22])[N:19]([CH3:20])[CH:18]=[N:8][C:7]=2[CH:6]=[CH:5]1)[CH:2]=[CH2:3]Participants
Procedure
To a room temperature solution of 5-allyl-4-chloro-5H-pyrrolo[3,2-d]pyrimidine (220 mg, 1.3 mmol, 1 equiv.) in 3 mL of DMF was added 60% NaH (100 mg, 2.5 mmol, 2 equiv.) followed by MeI (0.18 ml, 1.8 mmol, 1.5 equiv.). After 30 minutes, the mixture was diluted with water and extracted with EtOAc. The combined organic layers were dried, filtered, and concentrated in vacuo. The residue was purified by reverse phase HPLC (5-90% CH3CN/water+0.1% TFA). The desired fractions were combined and concentrated to remove CH3CN. The remaining aqueous mixture was extracted with EtOAc, dried, filtered, and evaporated to provide 152 mg (64%) of 5-allyl-3-methyl-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one as a yellow oil which was used without further purification.
Workup
- extractionextracted with EtOAc
- customThe combined organic layers were dried
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue was purified by reverse phase HPLC (5-90% CH3CN/water+0.1% TFA)
- concentrationconcentrated
- customto remove CH3CN
- extractionThe remaining aqueous mixture was extracted with EtOAc
- customdried
- filtrationfiltered
- customevaporated
Sources & evidence
- ORD record
- ord-7b18bbcdd92f4a0c9ff57180fd1089fb
- Source dataset
- uspto-grants-2014_02
- Patent number
- US08658637B2
Reaction notes
Loading…